Loading insider details...
Beta
Latest Form 4 (Mar 17, 2026): Purchase of 1,000 DRMA shares, $1.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 17, 2026 | Dermata Therapeutics, Inc. (DRMA) | Purchase | 1,000 | $1.3K |
| Jan 7, 2026 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 9,000 | n/a |
| Jan 14, 2025 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 8,000 | n/a |
| Jan 5, 2024 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 25,000 | n/a |
| Jan 5, 2023 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 50,000 | n/a |
| Jan 5, 2022 | Dermata Therapeutics, Inc. (DRMA) | Grant/Award | 15,000 | n/a |
| Aug 17, 2021 | Dermata Therapeutics, Inc. (DRMA) | Conversion | 9,162 | n/a |